Clinical Trials List
Protocol NumberTAI-003
Completed
2020-12-14 - 2025-04-30
Phase I
Recruiting2
-
Trial Applicant
Efficient Pharma Management Corp.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 高育青 Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Chien-Chung Lin Division of Hematology & Oncology
- Po-Lan Su Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
